The editors wanted to introduce an interesting and varied topic of UC and would like to thank prominent researchers of bladder cancer around the world who participated in this topic.
Current perspectives on novel systemic therapeutic agents beyond immune checkpoint inhibition in metastatic urothelial carcinoma
Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes
The focused issue “Urothelial Carcinoma” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Ja Hyeon Ku and Hyung Suk Kim are serving as the unpaid Guest Editors for the focused issue.